News
BDXA
0.0000
0.00%
0.00
BD <BDX.N>: BARCLAYS REINSTATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $202
Reuters · 1d ago
BD <BDX.N>: CITIGROUP CUTS TARGET PRICE TO $198 FROM $232
Reuters · 1d ago
NYSE ORDER IMBALANCE <BDX.N> 131426.0 SHARES ON SELL SIDE
Reuters · 2d ago
BD Launches $1.6 Billion Debt Tender Offer
Reuters · 2d ago
BD - AGGREGATE OFFER CAP OF $1.6 BLN FOR DEBT SECURITIES
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog​, Ecolab
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Spotify, DuPont, Hasbro
Reuters · 2d ago
BECTON, DICKINSON AND COMPANY <BDX.N>: WELLS FARGO CUTS TARGET PRICE TO $157 FROM $184
Reuters · 2d ago
BD <BDX.N>: CITIGROUP CUTS TARGET PRICE TO $232 FROM $233
Reuters · 2d ago
BD <BDX.N>: PIPER SANDLER CUTS TARGET PRICE TO $170 FROM $205
Reuters · 2d ago
BUZZ-Becton Dickinson falls after lowering profit forecast
Reuters · 2d ago
BD <BDX.N>: JEFFERIES CUTS TARGET PRICE TO $190 FROM $220
Reuters · 2d ago
BD <BDX.N>: RBC CUTS TARGET PRICE TO $172 FROM $210
Reuters · 2d ago
UPDATE 1-Becton Dickinson lowers 2026 profit forecast, shares fall
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Playboy, Ciena
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, Dynatrace
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE- Once Upon a Farm, Emerson, Momentus
Reuters · 3d ago
BD schließt Zusammenschluss von Biosciences & Diagnostic Solutions mit Waters ab
Reuters · 3d ago
Waters übernimmt BD Biosciences und Diagnostic Solutions
Reuters · 3d ago
More
Webull provides a variety of real-time BDXA stock news. You can receive the latest news about BECTON DICKINSON through multiple platforms. This information may help you make smarter investment decisions.
About BDXA
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.